Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 313 $ 60
Prepaid expenses 24 30
Total Current Assets 337 90
Intangible assets 0 25,262
Deposits 12 12
Operating lease right-to-use asset 133 0
Fixed assets, net 0 35
Total Other Assets 145 25,309
TOTAL ASSETS 482 25,399
Current Liabilities:    
Accounts payable 1,720 1,762
Accrued expenses 2,276 1,023
Accrued interest 1,456 432
Deferred rent 8 8
Operating lease liability 134 0
Note payable to related party 0 100
Line of credit 31 31
Convertible debentures 13,143 10,673
Total Current Liabilities 18,768 14,029
Total liabilities 18,768 14,029
Stockholders' Equity:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 66,891629 and 50,650,478 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively 67 51
Additional paid-in capital 547,675 540,171
Accumulated deficit (565,862) (528,685)
Noncontrolling interest (169) (169)
Total Stockholders' Equity (18,286) 11,370
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 482 25,399
Series C    
Stockholders' Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: 1 1
Series J    
Stockholders' Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: $ 2 $ 1